Todd Golub

Todd Golub is a cancer biologist and physician-scientist who has transformed cancer drug discovery through genomic approaches, including the development of the PRISM high-throughput drug sensitivity profiling platform that screens hundreds of compounds across thousands of cancer cell lines. His work has identified unexpected drug sensitivities and rational combination hypotheses including IO+targeted therapy combinations. He is a founding contributor to the Cancer Cell Line Encyclopedia (CCLE) and has pioneered the use of small molecule repurposing for cancer combination regimens.